Memantine Hydrochloride Memantine HCl CAS 41100-52-1 Assay 99.0%~101.0% API
Umenzi onobunyulu obuPhezulu kunye noMgangatho oZinzile
Igama leKhemikhali: Memantine Hydrochloride
CAS: 41100-52-1
I-Memantine Hydrochloride kunyango lwe-Alzheimer's disease
I-API USP Standard, uMgangatho oPhezulu, iMveliso yoRhwebo
Igama leMchiza | I-Memantine Hydrochloride |
Izithethantonye | Memantine HCl;I-3,5-Dimethyl-1-adamantanamine Hydrochloride |
Inombolo yeCAS | 41100-52-1 |
Inombolo yeCAT | RF-API43 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C12H22ClN |
Ubunzima beMolekyuli | 215.76 |
Indawo yokunyibilika | 292℃ |
Imeko yokuthumela ngenqanawa | Phantsi koBubushushu be-Ambient |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo weCrystal oMhlophe okanye oMhlophe |
Ukuchongwa | IR |
Ilahleko ekomisweni | ≤0.50% |
Iintsimbi ezinzima (Pb) | ≤10ppm |
Izinto ezinxulumeneyo | |
1-Methyladamantane | ≤0.30% (CAS 768-91-2) |
1,3,5-Trimethyladamantane | ≤0.30% (CAS 707-35-7) |
Nakuphi na Ukungcola Okungaziwayo | ≤0.10% |
Ukungcola ngokupheleleyo | ≤0.50% |
Intsalela yokunyibilika | I-Ethanol ≤0.05% |
Intsalela yokunyibilika | I-Ethylacetate ≤0.05% |
Ungcoliseko lweMicrobiological | Ubuninzi be-5 * 102 i-aerobes kunye ne-fungi nge-1g Akukho Escherichia coli |
Ubungakanani baMasuntswana aSasaziwe | Dlula i-100um |
pH | 4.5~6.5 |
Isivavanyi | 99.0% ~ 101.0% (kwisiseko esomileyo) |
Umgangatho woVavanyo | Umgangatho we-USP |
Ukusetyenziswa | I-Active Pharmaceutical Ingredient (API);Isifo sika-Alzheimer |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we-Memantine Hydrochloride (CAS: 41100-52-1) enomgangatho ophezulu.
I-Memantine Hydrochloride (i-CAS: i-41100-52-1) iyeza elaziwayo le-neuroprotective elisetyenziselwa unyango lwe-Alzheimer's Disease.Kukholelwa ukuba liyeza lokuqala le-neuroprotective eliye lafumana imvume yonyango yi-US FDA kunye neYurophu.
I-Memantine Hydrochloride, i-NMDA receptor antagonist, yaqulunqwa ngokubambisana yi-Forest Laboratories kunye ne-Merz Pharmaceuticals kwaye ithengiswe phantsi kwegama lezorhwebo elithi Namenda kunyango lwe-Alzheimer's disease e-US emva kokuvunywa kwayo ngo-Oktobha, 2003. Eli chiza liye lafumaneka kumazwe amaninzi aseYurophu. kunye neemarike zaseAsia ngaphambi kokufumana imvume e-US.